A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
NiKang Therapeutics, Inc.
AstraZeneca
Eli Lilly and Company
Kivu Bioscience Inc.
Pfizer
Exscientia AI Limited
Conjupro Biotherapeutics, Inc.
Wake Forest University Health Sciences
Sotio Biotech Inc.
Radiopharm Theranostics, Ltd
National Cancer Institute (NCI)
PMV Pharmaceuticals, Inc
NeoImmuneTech
Monte Rosa Therapeutics, Inc
Radiopharm Theranostics, Ltd
MacroGenics
SystImmune Inc.
SN BioScience
Boundless Bio, Inc.
Jacobio Pharmaceuticals Co., Ltd.
AbbVie
Janux Therapeutics
National Cancer Institute (NCI)
NiKang Therapeutics, Inc.
Incyte Corporation
University of Virginia
TransThera Sciences (Nanjing), Inc.
NRG Oncology
OncoC4, Inc.
Klus Pharma Inc.
Theratechnologies
SOLTI Breast Cancer Research Group
Stanford University
Cybrexa Therapeutics
Cyteir Therapeutics, Inc.
BeiGene
Carisma Therapeutics Inc
Tasly Biopharmaceuticals Co., Ltd.
National Cancer Institute (NCI)
Sellas Life Sciences Group
Vincerx Pharma, Inc.
AstraZeneca
Mundipharma Research Limited
Salubris Biotherapeutics Inc
Rhizen Pharmaceuticals SA
Pfizer
Xencor, Inc.
TransThera Sciences (Nanjing), Inc.
Exelixis